Marshall, Gerstein & Borun LLP

Representative Experience

• Drug Discovery 
• Pharmaceutical Formulations
• Cancer Biology

• Product Development

Background and Credentials

Dr. Vivien C. Nielsen obtained her J.D. from the University of Michigan Law School and is registered to practice with the U.S. Patent and Trademark Office.  As a law student, Dr. Nielsen was a Dean’s Scholar and a Contributing Editor to the Michigan Telecommunications and Technology Law Review.  She also served as President of the Intellectual Property Students Association.

Dr. Nielsen earned her Ph.D. in Pharmaceutical Sciences from the University of Michigan.  Her doctoral research focused on reducing drug resistance in cancer cells.  As a graduate student, she was awarded fellowships from the NIH, PhRMA Foundation, and American Foundation for Pharmaceutical Education.  Dr. Nielsen received a B.S. in Biology with a minor in Chemistry from Duke University.
 
In addition to her academic research, her previous experience working in R&D for large corporations such as Pfizer, Avon, and Unilever has given Dr. Nielsen technical knowledge valuable for achieving patent protection for a broad range of consumer products.

Publications

• S.H. Patel and V.C. Nielsen. "The Limited Benefits of Product-By-Process Claims.” Intellectual Property Today. 2009, 16(12), 22-23. 
• V.Y. Chen, M.M. Posada, L. Zhao and G.R. Rosania. “Rapid doxorubicin efflux from the nucleus of drug-resistant cancer cells following extracellular drug clearance.” Pharmaceutical Research. 2007, 24(11), 2156-2167. 
• V.Y. Chen, M.M. Posada, L.L. Blazer, T. Zhao and G.R. Rosania. “The role of the VPS4a-exosome pathway in the intrinsic egress route of a DNA-binding anticancer agent.” Pharmaceutical Research. 2006, 23(8), 1687-1695. 
• V.Y. Chen and G.R. Rosania. “The great multidrug resistance paradox.” American Chemical Society Chemical Biology. 2006, 1(5), 271-273. 

• V.Y. Chen, S.M. Khersonsky, K. Shedden, Y.T. Chang and G.R. Rosania. “The system dynamics of subcellular transport.” Molecular Pharmaceutics. 2004, 1(6), 414-425.

Community and Professional Involvement

• American Association of Pharmaceutical Scientists (AAPS)
• Intellectual Property Law Association of Chicago (IPLAC)

Short Biography